Published online Oct 18, 2015. doi: 10.4254/wjh.v7.i23.2492
Peer-review started: June 12, 2015
First decision: July 25, 2015
Revised: August 3, 2015
Accepted: August 30, 2015
Article in press: August 31, 2015
Published online: October 18, 2015
Processing time: 131 Days and 13.7 Hours
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is a novel 2-stage technique intended to induce rapid growth of the future liver remnant (FLR). Initial reports of a 12% mortality rate have sparked debate regarding the safety of the procedure. A 64 years old male was planned for a right-sided hemi-hepatectomy due to colorectal cancer liver metastases. Intra-operatively it was decided to convert to an ALPPS due to unexpectedly small segments 2-4. Post-operative serum laboratory tests indicated an acute liver failure and radiological imaging showed no sign of arterial blood flow to the right hemi-liver. A computed tomography examination on post-operative day 3 revealed that the FLR had increased from 290 to 690 mL in 3 d (138% growth). In the following days serum values gradually improved and stage 2 was carried out on post-operative day 7. The rest of the hospital stay was uneventful and the patient made a full recovery. ALPPS is a fascinating advancement in liver surgery. Despite severe post-operative complications, in properly selected cases it provides successful outcomes that other modalities of treatment cannot offer.
Core tip: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is a novel 2-stage technique intended to induce rapid growth of the future liver remnant. Initial reports of a 12% mortality rate have sparked debate regarding the safety of the procedure. We here present a complication following ALPPS that to our knowledge has never been described before. Yet proper patient selection resulted in a full recovery following a potentially life threatening liver failure.